Company profile

Evercrisp Biosciences company profile

Evercrisp Biosciences operates in the biotechnology sector, focusing on developing solutions for genetically validated but challenging drug targets. The company applies CRISPR technology in human therapeutics, aiming to address areas with significant unmet medical needs. Their research and development efforts are directed towards creating innovative genetic medicines and drug delivery systems. The company is involved in life sciences R&D and engineering, contributing to advancements in genetic medicine. Evercrisp Biosciences designs receptor-targeted miniproteins to enable precise, non-viral delivery of gene editing tools to difficult-to-reach tissues such as the brain, kidney, and muscle. Their platform also incorporates endosomal escape elements to improve..... For more information, log in to dureach.com to view the full company profile.

Business identity

Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$1K+
Founded
2021-01-01

Headquarters

Headquarters
Berkeley, California, United States
Postal code
94720
Country code
US
Continent
North America

Capital profile

Funding and company signals

No public funding data is available for this company.

Founders and investors

No public relation records are available.

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.